Filters
reset all| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
FSGS/Nephrotic Syndrome Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 25 | 56 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
High-Resolution Rapid Microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Rapid microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Invitae Expanded Renal Disease Panel Invitae United States | 693 | 388 |
|
Invitae United States | 59 | 16 |
|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
Centogene AG - the Rare Disease Company Germany | 11 | 2 |
|
Centogene AG - the Rare Disease Company Germany | 11 | 2 |
|
Centogene AG - the Rare Disease Company Germany | 58 | 28 |
|
Centogene AG - the Rare Disease Company Germany | 67 | 33 |
|
Centogene AG - the Rare Disease Company Germany | 114 | 68 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 8 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 11 | 2 |
|
GPC3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
BRCA2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 8 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.